Suchergebnisse - "Ham, Ahrong"

PubPharm (17)

1

Intrahepatic cholangiocarcinoma initially diagnosed as adenocarcinoma of unknown primary with hepatoduodenal ligament lymph node metastases : A case report

enthalten in: Oncology letters | 2024

von Noh, S. | Ham, A. | Gil, J. | +2

2

Real-World Outcomes of Nivolumab, Pembrolizumab, and Atezolizumab Treatment Efficacy in Korean Veterans with Stage IV Non-Small-Cell Lung Cancer

enthalten in: Cancers | 2023

von Ham, A. | Lee, Y. | Kim, H. | +1

3

Real-World Outcomes of Nivolumab, Pembrolizumab, and Atezolizumab Treatment Efficacy in Korean Veterans with Stage IV Non-Small-Cell Lung Cancer

enthalten in: ResearchSquare.com | 2023

von Ham, A. | Lee, Y. | Kim, H. | +1

4

New-onset type 1 diabetes mellitus as a delayed immune-related event after discontinuation of nivolumab : A case report

enthalten in: Medicine | 2022

von Seo, J. | Lim, T. | Ham, A. | +2

5

β‑catenin blockers enhance the effect of CDK4/6 inhibitors on stemness and proliferation suppression in endocrine‑resistant breast cancer cells

enthalten in: Oncology reports | 2022

von Ham, A. | Cho, M. | Won, H. | +2

6

Correction to : Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer

enthalten in: Breast cancer research and treatment | 2020

von Ham, A. | Kim, M. | Kim, G. | +8

ErratumFor: Breast Cancer Res Treat. 2020 Aug;183(1):107-116. - PMID 32577940

7

Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer

enthalten in: Breast cancer research and treatment | 2020

von Ham, A. | Kim, M. | Kim, G. | +8

ErratumIn: Breast Cancer Res Treat. 2020 Jul 14;:. - PMID 32661666

8

Correction to: Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer

enthalten in: Breast cancer research and treatment | 2020

von Ham, A. | Kim, M. | Kim, G. | +8

9

Correction to: Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer

enthalten in: Breast cancer research and treatment | 2020

von Ham, A. | Kim, M. | Kim, G. | +8

10

Correction to: Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer

enthalten in: Breast cancer research and treatment | 2020

von Ham, A. | Kim, M. | Kim, G. | +8